Kiora Stock Probability of Future Stock Price Finishing Under 8.5

KPRX
 Stock
  

USD 3.78  0.10  2.72%   

Kiora Pharmaceuticals' future price is the expected price of Kiora Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Kiora Pharmaceuticals performance during a given time horizon utilizing its historical volatility.
  
Please see Kiora Pharmaceuticals Backtesting, Kiora Pharmaceuticals Valuation, Kiora Pharmaceuticals Correlation, Kiora Pharmaceuticals Hype Analysis, Kiora Pharmaceuticals Volatility, Kiora Pharmaceuticals History as well as Kiora Pharmaceuticals Performance. Please specify Kiora Pharmaceuticals time horizon, a valid symbol (red box) and a target price (blue box) you would like Kiora Pharmaceuticals odds to be computed.

Kiora Pharmaceuticals Target Price Odds to finish below 8.5

The tendency of Kiora Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under $ 8.50  after 90 days
 3.78 90 days 8.50 
about 88.4
Based on a normal probability distribution, the odds of Kiora Pharmaceuticals to stay under $ 8.50  after 90 days from now is about 88.4 (This Kiora Pharmaceuticals probability density function shows the probability of Kiora Stock to fall within a particular range of prices over 90 days) . Probability of Kiora Pharmaceuticals price to stay between its current price of $ 3.78  and $ 8.50  at the end of the 90-day period is about 84.91 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.06 . This indicates Kiora Pharmaceuticals market returns are sensitive to returns on the market. As the market goes up or down, Kiora Pharmaceuticals is expected to follow. Additionally The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Kiora Pharmaceuticals is significantly underperforming NYSE Composite.
   Kiora Pharmaceuticals Price Density   
       Price  

Predictive Modules for Kiora Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kiora Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Kiora Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Kiora Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.193.7813.23
Details
Intrinsic
Valuation
LowReal ValueHigh
0.265.3014.75
Details
1 Analysts
Consensus
LowTarget PriceHigh
5.0010.0015.00
Details
Earnings
Estimates (2)
LowProjected EPSHigh
-1.47-1.33-1.19
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Kiora Pharmaceuticals. Your research has to be compared to or analyzed against Kiora Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Kiora Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Kiora Pharmaceuticals.

Kiora Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Kiora Pharmaceuticals is not an exception. The market had few large corrections towards the Kiora Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Kiora Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Kiora Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.74
β
Beta against NYSE Composite1.06
σ
Overall volatility
1.57
Ir
Information ratio -0.08

Kiora Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kiora Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kiora Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Kiora Pharmaceuticals generated a negative expected return over the last 90 days
Kiora Pharmaceuticals has high historical volatility and very poor performance
Net Loss for the year was (16.39 M) with loss before overhead, payroll, taxes, and interest of (5.14 M).
Kiora Pharmaceuticals currently holds about 2.43 M in cash with (10.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.64.

Kiora Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kiora Stock often depends not only on the future outlook of the current and potential Kiora Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kiora Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding114401.45
Cash And Short Term Investments7854690.00

Kiora Pharmaceuticals Technical Analysis

Kiora Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Kiora Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Kiora Pharmaceuticals. In general, you should focus on analyzing Kiora Stock price patterns and their correlations with different microeconomic environments and drivers.

Kiora Pharmaceuticals Predictive Forecast Models

Kiora Pharmaceuticals time-series forecasting models is one of many Kiora Pharmaceuticals' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Kiora Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Kiora Pharmaceuticals

Checking the ongoing alerts about Kiora Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Kiora Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Kiora Pharmaceuticals generated a negative expected return over the last 90 days
Kiora Pharmaceuticals has high historical volatility and very poor performance
Net Loss for the year was (16.39 M) with loss before overhead, payroll, taxes, and interest of (5.14 M).
Kiora Pharmaceuticals currently holds about 2.43 M in cash with (10.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.64.

Complementary Tools for analysis

When running Kiora Pharmaceuticals price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Is Kiora Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kiora Pharmaceuticals. If investors know Kiora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kiora Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
4.3 M
Return On Assets
(0.29) 
Return On Equity
(1.24) 
The market value of Kiora Pharmaceuticals is measured differently than its book value, which is the value of Kiora that is recorded on the company's balance sheet. Investors also form their own opinion of Kiora Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kiora Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kiora Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kiora Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kiora Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Kiora Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kiora Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.